JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1010278, encodeId=c80a10102e8dd, content=审稿速度:12.0 偏重的研究方向：蛋白构建方法 经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464a5581019, createdName=ms5000001638769144, createdTime=Sun Aug 22 12:30:13 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857476, encodeId=14b685e47685, content=19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Thu Feb 13 16:59:25 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539385, encodeId=9814539385c0, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520070, encodeId=06cc5200e062, content=审稿速度:2.0 经验分享：在编辑手里待了二十几天，然后就悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Fri Mar 11 00:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519263, encodeId=127151926315, content=谢谢medcardio 2016-02-16 发表:: 祝福必中！, beContent=medcardio 2016-02-16 发表:: 祝福必中！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Tue Feb 16 23:02:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519235, encodeId=1d765192352d, content=祝福必中！bjtly 2016-02-15 发表:: 今天投稿，求祝福~, beContent=bjtly 2016-02-15 发表:: 今天投稿，求祝福~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Feb 16 10:03:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519225, encodeId=666c519225a3, content=今天投稿，求祝福~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Mon Feb 15 23:03:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827458, encodeId=f87782e458cf, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Aug 15 08:33:00 CST 2013, time=2013-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497159, encodeId=c65149e15903, content=太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=liting711, createdTime=Mon Jul 01 11:34:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481575, encodeId=3f724815e525, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-08-22 ms5000001638769144

审稿速度:12.0
偏重的研究方向：蛋白构建方法
经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉

136 0

[GetPortalCommentsPageByObjectIdResponse(id=1010278, encodeId=c80a10102e8dd, content=审稿速度:12.0 偏重的研究方向：蛋白构建方法 经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464a5581019, createdName=ms5000001638769144, createdTime=Sun Aug 22 12:30:13 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857476, encodeId=14b685e47685, content=19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Thu Feb 13 16:59:25 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539385, encodeId=9814539385c0, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520070, encodeId=06cc5200e062, content=审稿速度:2.0 经验分享：在编辑手里待了二十几天，然后就悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Fri Mar 11 00:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519263, encodeId=127151926315, content=谢谢medcardio 2016-02-16 发表:: 祝福必中！, beContent=medcardio 2016-02-16 发表:: 祝福必中！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Tue Feb 16 23:02:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519235, encodeId=1d765192352d, content=祝福必中！bjtly 2016-02-15 发表:: 今天投稿，求祝福~, beContent=bjtly 2016-02-15 发表:: 今天投稿，求祝福~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Feb 16 10:03:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519225, encodeId=666c519225a3, content=今天投稿，求祝福~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Mon Feb 15 23:03:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827458, encodeId=f87782e458cf, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Aug 15 08:33:00 CST 2013, time=2013-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497159, encodeId=c65149e15903, content=太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=liting711, createdTime=Mon Jul 01 11:34:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481575, encodeId=3f724815e525, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2020-02-13 ms9016875260525266

19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考

69 0

[GetPortalCommentsPageByObjectIdResponse(id=1010278, encodeId=c80a10102e8dd, content=审稿速度:12.0 偏重的研究方向：蛋白构建方法 经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464a5581019, createdName=ms5000001638769144, createdTime=Sun Aug 22 12:30:13 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857476, encodeId=14b685e47685, content=19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Thu Feb 13 16:59:25 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539385, encodeId=9814539385c0, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520070, encodeId=06cc5200e062, content=审稿速度:2.0 经验分享：在编辑手里待了二十几天，然后就悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Fri Mar 11 00:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519263, encodeId=127151926315, content=谢谢medcardio 2016-02-16 发表:: 祝福必中！, beContent=medcardio 2016-02-16 发表:: 祝福必中！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Tue Feb 16 23:02:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519235, encodeId=1d765192352d, content=祝福必中！bjtly 2016-02-15 发表:: 今天投稿，求祝福~, beContent=bjtly 2016-02-15 发表:: 今天投稿，求祝福~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Feb 16 10:03:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519225, encodeId=666c519225a3, content=今天投稿，求祝福~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Mon Feb 15 23:03:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827458, encodeId=f87782e458cf, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Aug 15 08:33:00 CST 2013, time=2013-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497159, encodeId=c65149e15903, content=太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=liting711, createdTime=Mon Jul 01 11:34:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481575, encodeId=3f724815e525, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2017-07-18 chenyuming

3分边缘，希望能维持稳定，略有上升也不错。

245 0

[GetPortalCommentsPageByObjectIdResponse(id=1010278, encodeId=c80a10102e8dd, content=审稿速度:12.0 偏重的研究方向：蛋白构建方法 经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464a5581019, createdName=ms5000001638769144, createdTime=Sun Aug 22 12:30:13 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857476, encodeId=14b685e47685, content=19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Thu Feb 13 16:59:25 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539385, encodeId=9814539385c0, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520070, encodeId=06cc5200e062, content=审稿速度:2.0 经验分享：在编辑手里待了二十几天，然后就悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Fri Mar 11 00:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519263, encodeId=127151926315, content=谢谢medcardio 2016-02-16 发表:: 祝福必中！, beContent=medcardio 2016-02-16 发表:: 祝福必中！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Tue Feb 16 23:02:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519235, encodeId=1d765192352d, content=祝福必中！bjtly 2016-02-15 发表:: 今天投稿，求祝福~, beContent=bjtly 2016-02-15 发表:: 今天投稿，求祝福~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Feb 16 10:03:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519225, encodeId=666c519225a3, content=今天投稿，求祝福~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Mon Feb 15 23:03:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827458, encodeId=f87782e458cf, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Aug 15 08:33:00 CST 2013, time=2013-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497159, encodeId=c65149e15903, content=太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=liting711, createdTime=Mon Jul 01 11:34:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481575, encodeId=3f724815e525, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2016-03-11 jimzz

审稿速度:2.0
经验分享：在编辑手里待了二十几天，然后就悲剧了

290 0

[GetPortalCommentsPageByObjectIdResponse(id=1010278, encodeId=c80a10102e8dd, content=审稿速度:12.0 偏重的研究方向：蛋白构建方法 经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464a5581019, createdName=ms5000001638769144, createdTime=Sun Aug 22 12:30:13 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857476, encodeId=14b685e47685, content=19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Thu Feb 13 16:59:25 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539385, encodeId=9814539385c0, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520070, encodeId=06cc5200e062, content=审稿速度:2.0 经验分享：在编辑手里待了二十几天，然后就悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Fri Mar 11 00:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519263, encodeId=127151926315, content=谢谢medcardio 2016-02-16 发表:: 祝福必中！, beContent=medcardio 2016-02-16 发表:: 祝福必中！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Tue Feb 16 23:02:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519235, encodeId=1d765192352d, content=祝福必中！bjtly 2016-02-15 发表:: 今天投稿，求祝福~, beContent=bjtly 2016-02-15 发表:: 今天投稿，求祝福~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Feb 16 10:03:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519225, encodeId=666c519225a3, content=今天投稿，求祝福~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Mon Feb 15 23:03:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827458, encodeId=f87782e458cf, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Aug 15 08:33:00 CST 2013, time=2013-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497159, encodeId=c65149e15903, content=太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=liting711, createdTime=Mon Jul 01 11:34:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481575, encodeId=3f724815e525, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2016-02-16 jimzz

谢谢medcardio 2016-02-16 发表::
祝福必中！

medcardio 2016-02-16 发表:: 祝福必中！

254 0

[GetPortalCommentsPageByObjectIdResponse(id=1010278, encodeId=c80a10102e8dd, content=审稿速度:12.0 偏重的研究方向：蛋白构建方法 经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464a5581019, createdName=ms5000001638769144, createdTime=Sun Aug 22 12:30:13 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857476, encodeId=14b685e47685, content=19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Thu Feb 13 16:59:25 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539385, encodeId=9814539385c0, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520070, encodeId=06cc5200e062, content=审稿速度:2.0 经验分享：在编辑手里待了二十几天，然后就悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Fri Mar 11 00:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519263, encodeId=127151926315, content=谢谢medcardio 2016-02-16 发表:: 祝福必中！, beContent=medcardio 2016-02-16 发表:: 祝福必中！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Tue Feb 16 23:02:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519235, encodeId=1d765192352d, content=祝福必中！bjtly 2016-02-15 发表:: 今天投稿，求祝福~, beContent=bjtly 2016-02-15 发表:: 今天投稿，求祝福~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Feb 16 10:03:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519225, encodeId=666c519225a3, content=今天投稿，求祝福~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Mon Feb 15 23:03:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827458, encodeId=f87782e458cf, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Aug 15 08:33:00 CST 2013, time=2013-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497159, encodeId=c65149e15903, content=太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=liting711, createdTime=Mon Jul 01 11:34:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481575, encodeId=3f724815e525, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2016-02-16 medcardio

祝福必中！bjtly 2016-02-15 发表::
今天投稿，求祝福~

bjtly 2016-02-15 发表:: 今天投稿，求祝福~

377 0

[GetPortalCommentsPageByObjectIdResponse(id=1010278, encodeId=c80a10102e8dd, content=审稿速度:12.0 偏重的研究方向：蛋白构建方法 经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464a5581019, createdName=ms5000001638769144, createdTime=Sun Aug 22 12:30:13 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857476, encodeId=14b685e47685, content=19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Thu Feb 13 16:59:25 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539385, encodeId=9814539385c0, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520070, encodeId=06cc5200e062, content=审稿速度:2.0 经验分享：在编辑手里待了二十几天，然后就悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Fri Mar 11 00:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519263, encodeId=127151926315, content=谢谢medcardio 2016-02-16 发表:: 祝福必中！, beContent=medcardio 2016-02-16 发表:: 祝福必中！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Tue Feb 16 23:02:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519235, encodeId=1d765192352d, content=祝福必中！bjtly 2016-02-15 发表:: 今天投稿，求祝福~, beContent=bjtly 2016-02-15 发表:: 今天投稿，求祝福~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Feb 16 10:03:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519225, encodeId=666c519225a3, content=今天投稿，求祝福~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Mon Feb 15 23:03:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827458, encodeId=f87782e458cf, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Aug 15 08:33:00 CST 2013, time=2013-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497159, encodeId=c65149e15903, content=太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=liting711, createdTime=Mon Jul 01 11:34:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481575, encodeId=3f724815e525, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2016-02-15 jimzz

今天投稿，求祝福~

251 0

[GetPortalCommentsPageByObjectIdResponse(id=1010278, encodeId=c80a10102e8dd, content=审稿速度:12.0 偏重的研究方向：蛋白构建方法 经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464a5581019, createdName=ms5000001638769144, createdTime=Sun Aug 22 12:30:13 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857476, encodeId=14b685e47685, content=19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Thu Feb 13 16:59:25 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539385, encodeId=9814539385c0, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520070, encodeId=06cc5200e062, content=审稿速度:2.0 经验分享：在编辑手里待了二十几天，然后就悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Fri Mar 11 00:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519263, encodeId=127151926315, content=谢谢medcardio 2016-02-16 发表:: 祝福必中！, beContent=medcardio 2016-02-16 发表:: 祝福必中！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Tue Feb 16 23:02:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519235, encodeId=1d765192352d, content=祝福必中！bjtly 2016-02-15 发表:: 今天投稿，求祝福~, beContent=bjtly 2016-02-15 发表:: 今天投稿，求祝福~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Feb 16 10:03:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519225, encodeId=666c519225a3, content=今天投稿，求祝福~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Mon Feb 15 23:03:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827458, encodeId=f87782e458cf, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Aug 15 08:33:00 CST 2013, time=2013-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497159, encodeId=c65149e15903, content=太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=liting711, createdTime=Mon Jul 01 11:34:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481575, encodeId=3f724815e525, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2013-08-15 ms8472206870533718

审稿速度:1.0 | 投稿命中率:75.0
经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。

50 0

[GetPortalCommentsPageByObjectIdResponse(id=1010278, encodeId=c80a10102e8dd, content=审稿速度:12.0 偏重的研究方向：蛋白构建方法 经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464a5581019, createdName=ms5000001638769144, createdTime=Sun Aug 22 12:30:13 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857476, encodeId=14b685e47685, content=19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Thu Feb 13 16:59:25 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539385, encodeId=9814539385c0, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520070, encodeId=06cc5200e062, content=审稿速度:2.0 经验分享：在编辑手里待了二十几天，然后就悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Fri Mar 11 00:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519263, encodeId=127151926315, content=谢谢medcardio 2016-02-16 发表:: 祝福必中！, beContent=medcardio 2016-02-16 发表:: 祝福必中！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Tue Feb 16 23:02:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519235, encodeId=1d765192352d, content=祝福必中！bjtly 2016-02-15 发表:: 今天投稿，求祝福~, beContent=bjtly 2016-02-15 发表:: 今天投稿，求祝福~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Feb 16 10:03:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519225, encodeId=666c519225a3, content=今天投稿，求祝福~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Mon Feb 15 23:03:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827458, encodeId=f87782e458cf, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Aug 15 08:33:00 CST 2013, time=2013-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497159, encodeId=c65149e15903, content=太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=liting711, createdTime=Mon Jul 01 11:34:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481575, encodeId=3f724815e525, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2013-07-01 liting711

太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。

334 0

[GetPortalCommentsPageByObjectIdResponse(id=1010278, encodeId=c80a10102e8dd, content=审稿速度:12.0 偏重的研究方向：蛋白构建方法 经验分享：终于中稿了！！2020年10月份投的，这个期刊相对较慢！三个多月都待在编辑手里，之后送外审，修改拖了小半年，这期间还催了好几次，也说是期刊的稿件过多，考虑疫情原因之类的巴拉巴拉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464a5581019, createdName=ms5000001638769144, createdTime=Sun Aug 22 12:30:13 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857476, encodeId=14b685e47685, content=19年12月中旬投稿，在编辑手中较长，1个月的适合仍未送审，发邮件询问回复是编辑正在考虑，2月初网站显示建议转投。总体是：1. 编辑手里3个月没有送审；2. 理由是杂志社稿件过多；3. 没有给任何专业意见。供其他同学参考 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Thu Feb 13 16:59:25 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539385, encodeId=9814539385c0, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520070, encodeId=06cc5200e062, content=审稿速度:2.0 经验分享：在编辑手里待了二十几天，然后就悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Fri Mar 11 00:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519263, encodeId=127151926315, content=谢谢medcardio 2016-02-16 发表:: 祝福必中！, beContent=medcardio 2016-02-16 发表:: 祝福必中！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Tue Feb 16 23:02:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519235, encodeId=1d765192352d, content=祝福必中！bjtly 2016-02-15 发表:: 今天投稿，求祝福~, beContent=bjtly 2016-02-15 发表:: 今天投稿，求祝福~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Feb 16 10:03:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519225, encodeId=666c519225a3, content=今天投稿，求祝福~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F9C60DFC048932.jpg, createdBy=308c1677602, createdName=jimzz, createdTime=Mon Feb 15 23:03:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827458, encodeId=f87782e458cf, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：本人2013年6月8日投稿，6月28日审稿人开始审稿，8月14日返回意见，编辑拒稿，一共2个审稿人，提出了很多意见，很中肯，也很尖锐。审稿速度不是很快。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Aug 15 08:33:00 CST 2013, time=2013-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497159, encodeId=c65149e15903, content=太玄了，比去年还跌了一点，明年能不能保3分，感觉都不靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=liting711, createdTime=Mon Jul 01 11:34:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481575, encodeId=3f724815e525, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2011-06-29 med—doctor

明年会不会再跌呀，万一跌破怎么办？

378 0

内科

外科

专科科室

热点

按科室浏览

科研工具

写作工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务